INFUSYSTEM HOLDINGS, INC Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
INFUSYSTEM HOLDINGS, INC (INFU) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $331.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-04
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $331.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $505.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $211.00K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $413.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $331.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $505.00K 10-Q · filed 2026-05-08 |
| 2025-09-30 | $211.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $413.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $562.00K 10-Q · filed 2025-05-08 |
| 2024-09-30 | $248.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $495.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $743.00K 10-Q · filed 2024-05-09 |
| 2023-09-30 | $248.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $495.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $743.00K 10-Q · filed 2023-05-09 |
| 2022-09-30 | $369.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.07M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.78M 10-Q · filed 2022-05-05 |
| 2021-09-30 | $998.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.12M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.04M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $1.06M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.13M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.21M 10-Q · filed 2020-05-15 |
| 2019-09-30 | $1.08M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.15M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $3.28M 10-Q · filed 2019-05-15 |
| 2018-09-30 | $1.14M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $2.30M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.46M 10-Q · filed 2018-05-14 |
| 2017-09-30 | $1.38M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.77M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.15M 10-Q · filed 2017-05-15 |
| 2016-09-30 | $1.67M 10-Q · filed 2016-12-12 |
| 2016-06-30 | $3.32M 10-Q/A · filed 2016-12-12 |
| 2016-03-31 | $4.16M 10-Q/A · filed 2016-12-12 |
| 2015-09-30 | $1.00M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.89M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $2.58M 10-Q · filed 2015-05-12 |
| 2014-09-30 | $749.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.24M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $1.87M 10-Q · filed 2014-05-05 |
| 2013-09-30 | $646.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.29M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $1.94M 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |